Nor Neostigmine
CAS: 16088-19-0
Ref. 3D-RAA08819
| 1g | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
Nor Neostigmine
Sinónimos:
- 16088-19-0
- 3-(Dimethylamino)Phenyl Dimethylcarbamate
- Carbamic acid, dimethyl-, 3-(dimethylamino)phenyl ester
- Carbamic acid, dimethyl-, m-(dimethylamino)phenyl ester
- Dimethylcarbamic Acid 3-(Dimethylamino)phenyl Ester
- Norneostigmine
- carbamic acid, N,N-dimethyl-, 3-(dimethylamino)phenyl ester
- 3-(Dimethylamino)phenyl N,N-dimethylcarbamate
Descrição:
Nor Neostigmine is a cholinesterase inhibitor, which is used to treat patients with myasthenia gravis. It works by blocking the breakdown of acetylcholine at the neuromuscular junction, thereby increasing its concentration in the synaptic cleft and improving muscle contractions. Nor Neostigmine has been shown to be effective for treatment of diabetic neuropathy and other diseases that result from decreased cholinergic activity. The drug has also been shown to have a beneficial effect on locomotor activity in rats. Nor Neostigmine is not active against human immunodeficiency virus or inflammatory diseases of the intestine.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
208.26 g/mol
Fórmula:
C11H16N2O2
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
